Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Feb 2012 for RESPONSE GENETICS INC, €28k.
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -22.5%Entry 1.69 · Close at T+365 1.31
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Gary D. Nusbaum: trading record in brief
All filings by Gary D. Nusbaum on record concern Response Genetics Inc. Between 3 August 2010 and 2 February 2012, the trades on record add up to 2 filings.
No open-market sale appears; the market trades are 1 purchase worth €28k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 option exercise. 2012 to date brings 1 purchase and no sales.
On 6 February 2012 came the latest disclosure, an open-market purchase for €28k in Response Genetics Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Gary D. Nusbaum
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
25,000 shares@ US$1.50Common Stock, par value $0.01 per shareSEC:0001144204-12-006174:0
Canonical exit: 2 May 2012 (T+90)
4,312 shares@ US$1.35Common StockSEC:0001144204-10-041455:0
2 of 2 declarations
